HOME >> BIOLOGY >> NEWS
Treat the woman, not her age

Washington, DC -- Women age 65 years or older constitute half of new breast cancer patients each year, and the number of older women with breast cancer is forecast to double by 2030 as the baby boomers age. Yet despite their increasingly large numbers, older women who develop breast cancer often fail to receive the same care as offered to younger women according to Jeanne Mandelblatt, M.D., of Georgetown University's Lombardi Comprehensive Cancer Center.

In an editorial entitled "Treating Breast Cancer: The Age Old Dilemma of Old Age" which appears in the September 20, 2006, issue of the Journal of Clinical Oncology, she calls on doctors treating breast cancer in older women to look beyond the year in which a woman was born and to take into account her overall health, frailty and ability to tolerate various cancer treatment. "Older women who perceive more ageism in their interaction with providers are less likely to receive radiation or chemotherapy," Mandelblatt wrote.

Women want their physicians to consider their disease, not their birthdays. "In our work with older women, we found that 33 percent would choose chemotherapy if it would extend their lives by 12 or more months," she said.

Older women in good health may do better than younger women in poorer health. "At this time, we do not need more research to document what we already know: older women get less intensive treatment. What we need is an understanding of the biology of cancer in this population [women 65 or older with breast cancer], tools that can help clinicians identify physiological reserve and ability to withstand the rigors of more aggressive treatment, and more consistent elicitation of women's informed preferences."


'"/>

Contact: Cindy Fox-Aisen
cfa3@georgetown.edu
202-687-5100
Georgetown University Medical Center
3-Oct-2006


Page: 1

Related biology news :

1. Treatment-induced growth factor causes cancer progression
2. Treating male infertility with stem cells
3. Treatment extends survival in mouse model of spinal muscular atrophy
4. Water Treatment and Reuse -- II
5. Treatments for urinary infections leave bacteria bald, happy and vulnerable
6. Treatment disconnect in kidney cancer: Rising mortality despite more small tumors, more surgery
7. Antarctic Treaty Meeting moves to protect frozen continent from non-native species
8. Antarctic Treaty Meeting - Media opportunities
9. Evolving Issues in the Prevention and Treatment of Influenza: A media forum
10. Antarctic Treaty Consultative Meeting XXIX and Discover Antarctica! come to Edinburgh
11. NHLBI media availability: Treatment shows long-term benefits for cystic fibrosis patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2017)... Solutions, a global clinical research organization (CRO), announces the launch of ... 4, 2017. Shadow is designed to assist medical writers and biometrics ... the European Medicines Agency (EMA) in meeting the requirements for de-identifying ... ... ...
(Date:7/20/2017)... DAL ) customers now can use fingerprints instead of their ... (DCA). ... launches biometrics to board aircraft at Reagan Washington National Airport ... Delta,s biometric boarding pass experience that launched in May at ... process to allow eligible Delta SkyMiles Members who are enrolled in CLEAR ...
(Date:6/14/2017)... 15, 2017  IBM (NYSE: IBM ) is introducing several ... dedicated to developing collaboration between startups and global businesses, taking ... During the event, nine startups will showcase the solutions they ... industries. France is ... with a 30 percent increase in the number of startups ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the main ... people each year. Especially those living in larger cities are affected by air pollution ... of the most pollution-affected countries globally - decided to take action. , “I knew ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
Breaking Biology Technology:
Cached News: